Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pomalidomide

EU orphan designation number: EU/3/09/672   
Active ingredient: Pomalidomide
Indication: Treatment of multiple myeloma
Sponsor: Celgene Europe B.V.
Winthontlaan 6 N, 3526 KV Utrecht, Nederland
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Imnovid on 5/08/2013 with the number EU/1/13/850

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2009 Orphan designation EMEA/OD/053/09 (2009)7847 of 8/10/2009
30/05/2011 Change of name and/or address of sponsor EMEA/OD/053/09
13/06/2013 Other procedure
27/07/2018 Transfer of orphan designation EMEA/OD/053/09/T/01 (2018)5041 of 25/07/2018